When digital health giants Teladoc and Livongo announced their $18.5 billion merger, shares in both companies fell sharply as investors tried to work out the rationale for the deal. Now the dust ...

Its Livongo Health for diabetes, pre-diabetes, and hypertension were all named as preferred options in their categories, Express Scripts’ nod is especially notable considering how crowded the ...

is best known for its role in identifying and growing Livongo, a chronic-care company that sold for $13.9 billion, a record exit for a digital-health company, in October 2020. Alyssa Jaffee ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In January, digital health startup Transcarent, whose CEO Glen Tullman founded Livongo, announced plans to take Accolade private in a deal valued at roughly $621 million.

On August 5, telehealth giant Teladoc struck an $18.5 billion deal to buy Livongo, a chronic-care company. It's the biggest deal in digital health history, and it's sending shockwaves through an ...

Teladoc shares fell after the company reported fourth-quarter results that showed slowing revenue growth and weak guidance.

It purchased medical consultation company Best Doctors in 2017, Arlington-based virtual care provider Advance Medical in 2018 and health management program company Livongo in 2020. Originally ...

It sells its products and services under the BetterHelp, Teladoc, and Livongo brands. The company serves individual members, hospitals & health systems, employers, insurance & financial services ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...